Breaking News Instant updates and real-time market news.

AMD

AMD

$29.13

-2.28 (-7.26%)

15:18
10/02/18
10/02
15:18
10/02/18
15:18

Technical Take: AMD retraces near lows of the day

The shares are making a round-trip back to the lows, last at $28.99 and down over 7.6% on the day. At that price next support is at the low of the day at $28.71 and then at the $28 area. Resistance is at the $30 area.

  • 08

    Oct

AMD AMD
$29.13

-2.28 (-7.26%)

10/01/18
LEHM
10/01/18
NO CHANGE
Target $25
LEHM
Underweight
AMD price target raised to $25 from $15 at Barclays
Barclays analyst Blayne Curtis raised his price target for AMD (AMD) to $25 from $15 but keeps an Underweight rating on the shares. The analyst this morning also downgraded Intel (INTC) to Underweight from Equal Weight. Curtis, who admits he's surprised by how quick investors were to give AMD credit for server share gains, says "there's no denying" AMD will have large performance gains in the EPYC 2 generation and that it is well known at this point that Intel's roadmap is facing challenges with a 10nm server product ready mid-2020, at best. What's not talked about enough is what action Intel will take in the absence of competitive parts to retain share, Curtis tells investors in a research note titled "Advanced Micro Devices: Positioned To Start a Fight but Also Expect Some Punches Back."
10/01/18
BARD
10/01/18
DOWNGRADE
Target $28
BARD
Neutral
AMD downgraded to Neutral at Baird on high expectations, valuation
Baird analyst Tristan Gerra downgraded AMD (AMD) to Neutral from Outperform, telling investors in a research note that while the company's fundamentals continue to improve, he believes expectations and valuation are high. Gerra raised his price target to $28 from $20, but says he believes most good news are already priced in and that AMD's share gains in PCs in the face of Intel's (INTC) shortages may be limited given Intel's incremental capital investments.
10/01/18
10/01/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Underweight from Equal Weight at Barclays with analyst Blayne Curtis saying end-market tailwinds that propelled the run in shares, namely PC shortages and the slowing of server growth, are likely to reverse. 2. Chipotle (CMG) downgraded to Underperform from Perform at Oppenheimer with analyst Brian Bittner saying since its new CEO announcement in February, Chipotle is up 82% and has been upgraded 10 different times by the Street. 3. AMD (AMD) downgraded to Neutral from Outperform at Baird with analyst Tristan Gerra saying while the company's fundamentals continue to improve, he believes expectations and valuation are high. 4. Huntsman (HUN) downgraded to Neutral from Buy at Citi with analyst P.J. Juvekar saying he sees a lack of near-term catalysts for the next few quarters "in the backdrop of a well-telegraphed normalization in MDI profits." 5. Autohome (ATHM) downgraded to Sell from Hold at 86 Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/01/18
10/01/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. OPCO CUTS CHIPOTLE TO UNDERPERFORM: Oppenheimer analyst Brian Bittner downgraded Chipotle Mexican Grill (CMG) to Underperform from Perform with a $400 price target. Since its new CEO announcement in February, Chipotle is up 82% and has been upgraded 10 different times by the Street, Bittner noted. The company's "high-flying" valuation has "priced in" persistent mid-single same-store-sales and a path to at least $20 of earnings per share versus $8-$9 this year, the analyst added. His work suggests this earnings path is too optimistic, even when assuming "healthy sales." INTEL CUT TO UNDERWEIGHT BY BARCLAYS: Barclays analyst Blayne Curtis downgraded Intel (INTC) to Underweight from Equal Weight and lowered his price target for the shares to $38 from $53. End-market tailwinds that propelled the run in shares, namely PC shortages and the slowing of server growth, are likely to reverse, Curtis believes. Further, the analyst expects Intel will see increased competition from AMD (AMD) and declining free cash flow returns. In addition, the names that have been floated in the CEO search "have yet to yield any disruptive potential candidates to take on all of these challenges," Curtis said. By squandering its manufacturing lead, the company now faces a "costly battle to retain share amidst a near-term slowing of its end markets," concluded the analyst. MKM CUTS INFINERA TO SELL: MKM Partners analyst Michael Genovese downgraded Infinera (INFN) to Sell from Neutral and lowered his price target to $5.50 from $10. The analyst said his checks suggest the company's loss of its biggest customer CenturyLink (CTL) to Ciena (CIEN) amid concerns with its ability to produce "new leading edge digital signal processors every 18-30 months". Genovese expects Infinera's upcoming guidance for Q4 and FY19 to be disappointing on revenues and margins, while his price target that assumes a valuation multiple of 0.8-times enterprise value to expected FY19 sales "reflects increasing concerns about the long-term competitiveness of the company." TEVA UPGRADED AT LEERINK, GOLDMAN: Leerink analyst Ami Fadia upgraded Teva (TEVA) to Market Perform from Underperform due to improving business fundamentals as well as the improving multiples for the overall generics sector. The analyst, who believes the company's fundamentals have improved meaningfully and put Teva in a position to pay down $3.5B in debt by YE18, raised his price target on the shares to $24 from $16. Meanwhile, Goldman Sachs analyst Jami Rubin added Teva to Goldman's Conviction List with a Buy rating, calling the recent selloff in the shares a "head scratcher." Recent concerns raised in the marketplace regarding second half of 2018 headwinds and Eli Lilly's (LLY) galcenuzemab approval were already expected and well understood, Rubin tells investors in a research note. DEUTSCHE CUTS LAM RESEARCH, APPLIED MATERIALS TO HOLD: Deutsche Bank analyst Sidney Ho downgraded Lam Research (LRCX) to Hold and lowered his price target for the shares to $170 from $230, and downgraded Applied Materials (AMAT) to Hold and lowered his price target for the shares to $43 from $58. Semicap Equipment stocks are not expensive but lack positive catalysts, Ho said. The analyst believes investor fears over that the industry has reached a cyclical peak will remain as long as the memory market stays weak. Further, he sees risk is for additional capex push-outs, especially in the first half of 2019.

TODAY'S FREE FLY STORIES

10:30
10/18/18
10/18
10:30
10/18/18
10:30
General news
EIA Natural Gas Storage Change for the week ending October 12 »

Gas Inventories 81 Bcf…

10:30
10/18/18
10/18
10:30
10/18/18
10:30
General news
EIA Natural Gas Storage Change for the week ending October 12 »

Gas Inventories 81 Bcf…

MU

Micron

$41.57

-0.79 (-1.87%)

10:30
10/18/18
10/18
10:30
10/18/18
10:30
Options
1.7K Micron Nov 47 - Dec 52.5 call spreads trade 68c »

1.7K Micron Nov 47 - Dec…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,101.22

-14.77 (-1.32%)

, GOOGL

Alphabet Class A

$1,111.60

-15.07 (-1.34%)

10:28
10/18/18
10/18
10:28
10/18/18
10:28
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

GOOG

Alphabet

$1,101.22

-14.77 (-1.32%)

GOOGL

Alphabet Class A

$1,111.60

-15.07 (-1.34%)

BJ

BJ's Wholesale

$23.62

-0.35 (-1.46%)

CMCSA

Comcast

$36.38

-0.01 (-0.03%)

TRI

Thomson Reuters

$47.07

0.25 (0.53%)

ATOM

Atomera

$4.55

-0.1 (-2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 03

    Mar

IBM

IBM

$131.93

-2.12 (-1.58%)

, GPS

Gap

$25.89

-1.24 (-4.57%)

10:28
10/18/18
10/18
10:28
10/18/18
10:28
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

IBM

IBM

$131.93

-2.12 (-1.58%)

GPS

Gap

$25.89

-1.24 (-4.57%)

YUM

Yum! Brands

$90.34

-1.03 (-1.13%)

ENLK

EnLink Midstream Partners

$18.27

-0.08 (-0.44%)

WING

Wingstop

$72.38

-1.55 (-2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 29

    Oct

  • 07

    Nov

  • 13

    Nov

  • 03

    Mar

NKE

Nike

$76.52

0.02 (0.03%)

, UAL

United Continental

$88.41

-0.09 (-0.10%)

10:28
10/18/18
10/18
10:28
10/18/18
10:28
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

NKE

Nike

$76.52

0.02 (0.03%)

UAL

United Continental

$88.41

-0.09 (-0.10%)

GNRC

Generac

$57.53

1.23 (2.18%)

PTI

Proteostasis

$7.85

5.96 (315.34%)

SB

Safe Bulkers

$2.69

0.11 (4.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TEVA

Teva

$21.53

0.34 (1.60%)

, MYL

Mylan

$32.58

-0.45 (-1.36%)

10:25
10/18/18
10/18
10:25
10/18/18
10:25
Recommendations
Teva, Mylan, Amneal Pharmaceuticals, Novartis analyst commentary  »

Sandoz results…

TEVA

Teva

$21.53

0.34 (1.60%)

MYL

Mylan

$32.58

-0.45 (-1.36%)

AMRX

Amneal Pharmaceuticals

$18.66

0.17 (0.92%)

NVS

Novartis

$86.38

1.04 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 01

    Nov

  • 07

    Nov

  • 07

    Nov

  • 13

    Nov

  • 28

    Feb

ETP

Energy Transfer Partners

$21.75

-0.055 (-0.25%)

, ETE

Energy Transfer Equity

$17.00

-0.05 (-0.29%)

10:25
10/18/18
10/18
10:25
10/18/18
10:25
Conference/Events
Energy Transfer Partners to host special shareholder meeting »

Special shareholder…

ETP

Energy Transfer Partners

$21.75

-0.055 (-0.25%)

ETE

Energy Transfer Equity

$17.00

-0.05 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

AAPL

Apple

$218.70

-2.5 (-1.13%)

10:21
10/18/18
10/18
10:21
10/18/18
10:21
Periodicals
EU won't pursue action against Ireland over Apple tax bill, Independent says »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHAS

PhaseBio

$0.00

(0.00%)

10:21
10/18/18
10/18
10:21
10/18/18
10:21
Syndicate
PhaseBio opens at $5.00, IPO priced at $5.00 »

Citi, Cowen and Stifel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

GE

General Electric

$12.21

0.015 (0.12%)

10:20
10/18/18
10/18
10:20
10/18/18
10:20
Options
Earnings hedge in GE »

Earnings hedge in GE. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:20
10/18/18
10/18
10:20
10/18/18
10:20
General news
U.S. leading index rose 0.5% to 111.8 in September »

U.S. leading index rose…

10:20
10/18/18
10/18
10:20
10/18/18
10:20
General news
Today's U.S. reports »

Today's U.S. reports…

10:20
10/18/18
10/18
10:20
10/18/18
10:20
General news
Treasury Action: yields are loitering near highs »

Treasury Action: yields…

10:20
10/18/18
10/18
10:20
10/18/18
10:20
General news
FX Action: The dollar »

FX Action: The dollar was…

LGND

Ligand

$207.27

4.52 (2.23%)

, NVS

Novartis

$86.49

1.15 (1.35%)

10:18
10/18/18
10/18
10:18
10/18/18
10:18
Recommendations
Ligand, Novartis analyst commentary  »

Ligand current valuation…

LGND

Ligand

$207.27

4.52 (2.23%)

NVS

Novartis

$86.49

1.15 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 06

    Nov

  • 07

    Nov

PTE

PolarityTE

$13.78

-0.81 (-5.55%)

10:17
10/18/18
10/18
10:17
10/18/18
10:17
Hot Stocks
Breaking Hot Stocks news story on PolarityTE »

PolarityTE trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$230.34

-4.3 (-1.83%)

10:17
10/18/18
10/18
10:17
10/18/18
10:17
Downgrade
Thermo Fisher rating change  »

Follow-up: Thermo Fisher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 24

    Oct

HAL

Halliburton

$38.78

-0.78 (-1.97%)

10:17
10/18/18
10/18
10:17
10/18/18
10:17
Downgrade
Halliburton rating change  »

Follow-up: Halliburton…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
10/18/18
10/18
10:17
10/18/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPN

Superior Energy

$9.23

-0.39 (-4.05%)

10:17
10/18/18
10/18
10:17
10/18/18
10:17
Downgrade
Superior Energy rating change  »

Follow-up:Superior Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
10/18/18
10/18
10:16
10/18/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTE

PolarityTE

$13.78

-0.81 (-5.55%)

10:16
10/18/18
10/18
10:16
10/18/18
10:16
Hot Stocks
PolarityTE jumps 2% to $14.94 after Citron calls shares 'a zero' »

In a new research report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVI

Activision Blizzard

$71.72

-6.53 (-8.35%)

10:15
10/18/18
10/18
10:15
10/18/18
10:15
Recommendations
Activision Blizzard analyst commentary  »

Activision's CoD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
10/18/18
10/18
10:15
10/18/18
10:15
General news
Breaking General news story  »

Week of 10/12 EIA Natural…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.